Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop diabetes after immunotherapy.

There are at least six kinds of diabetes you should know about. Endocrinologists explain the causes, symptoms, and treatments for type 1, type 2, and more.

In a US Phase I and II clinical trial evaluating another FcR-nonbinding anti-CD3 antibody (teplizumab or hOKT3γ1 Ala–Ala) at the time of onset of Type 1 diabetes, anti-CD3 treatment halted the ...

Bioresponsive materials have gained prominence as innovative tools for advancing drug delivery systems, particularly in managing type 1 and type 2 diabetes mellitus. These materials respond to biological stimuli such as pH,